Rapport Therapeutics, Inc.
Q3 2025 13F Holders
Symbol
RAPP
CUSIP
75383L102
Type
Equity
Class
COM
Num filings
133
Total reported value, excl. options
$1.46 B
Compare 2025 Q3 to
2025 Q4
2025 Q2
2025 Q1
2024 Q4
2024 Q3
2024 Q2
Manager
Report Date
Value ($000)
Shares
Option Type